WHO recommends Veklury for high-risk patients
WHO have stated that Veklury recommendation is being updated following compelling new evidence of hospital reductions
Read More
Tag: Veklury
Gilead’s Veklury should be effective against COVID-19 variants
Company has completed genetic analysis for UK and South African variants
Read More
Gilead’s COVID-19 drug remdesivir bags US approval
Antiviral becomes first COVID-19 treatment approved in the US
Read More
Eight medicines leap towards EU approval
The recommendations include a conditional approval for Gilead’s Veklury (remdesivir) for COVID-19
Read More
CHMP backs approval of remdesivir as COVID-19 treatment
The drug is the first to be recommended as a treatment for the virus in the EU
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
